Jing Liu

Practice Areas

专利无效、专利行政诉讼、专利侵权诉讼

patent invalidation, patent administrative litigation, patent infringement litigation

Career

律师 Lawyer

Professional Memberships

中国律师执业资格 PRC Bar

中国药学会医药知识产权研究专业委员会-青年委员

Young Committee Member of the Pharmaceutical Intellectual Property Professional Committee, Chinese Pharmaceutical Association

东城律协知识产权业务研究会-委员

Member of the Intellectual Property Business Research Committee, Dongcheng Lawyers Association

Clients

北京四环制药有限公司

Beijing Shihuan Pharmaceutical Co., Ltd.

重庆药友制药有限责任公司

Chongqing Yaopharma Co., Ltd.

四川新绿色药业科技发展有限公司

Sichuan New Green Pharmaceutical Technology Development Co., Ltd.

深圳迈瑞生物医疗电子股份有限公司

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Industry Sector Expertise

知识产权 专利（生物、医药、化学）

Intellectual Property · Patents (Biology, medicine, chemistry)

Languages Spoken

中文，英文

Chinese, English

Work Highlights

刘静律师曾就职于国家知识产权局专利局化学发明审查部、专利复审委员会，拥有十七年专利复审委员会经验，曾审理多件重大、疑难无效案件，包括专利复审委员会十大案件、以及在业内引起广泛关注的知名案件，深耕化学医药领域的无效案件和诉讼。

Attorney Liu Jing previously served at the Patent Office of the China National Intellectual Property Administration (CNIPA), working in the Chemical Invention Examination Department and the Patent Reexamination Board. With seventeen years of experience at the Patent Reexamination Board, she has adjudicated numerous major and complex invalidation cases, including several of the Board's "Top Ten Cases" and high-profile cases that garnered significant attention within the industry. She specializes in invalidation and litigation cases in the chemical and pharmaceutical fields.

刘静律师曾参与2020-2021的《专利审查指南》修改工作，承担“药品专利链接”专题的修改，首批“知识产权行政裁决技术调查官”，曾承担多项课题、多次宣讲十大案件。作为专利诉讼律师，承办若干典型案件、在业内反响较大案件。

Attorney Liu Jing participated in the revision of the Patent Examination Guidelines (2020-2021), taking charge of amendments related to the "Pharmaceutical Patent Linkage" section. She was among the first group of "Technical Investigators for Intellectual Property Administrative Adjudication" and has led multiple research projects while frequently lecturing on the Board's Top Ten Cases. As a patent litigation attorney, she has handled several landmark cases, including those that generated substantial impact within the legal and intellectual property sectors.

代理 “桂哌齐特” 金奖专利无效案的行政诉讼纠纷

The administrative litigation dispute over the invalidation of the gold medal patent for the agent "Cinepazide"

代理 “索拉非尼”专利无效案的行政诉讼纠纷（被最高人民法院选为2023年426知识产权宣传周公开审理案件）

The administrative litigation dispute over the invalidation of the patent for "Sorafenib" (selected by the Supreme People's Court as a publicly heard case during the 2023 Intellectual Property Awareness Week in April)

代理宁德新能源与竞争对手的专利无效案件的行政诉讼纠纷

administrative litigation dispute over the invalidation of patents between ATL (Amperex Technology Limited) and its competitors.

代理“乌帕替尼”专利无效案件的行政诉讼纠纷

he administrative litigation dispute over the patent invalidation case of the agent for "Upadacitinib"

代理“索磷布韦”专利的系列侵权纠纷行政裁决案、行政诉讼纠纷、以及专利无效案件

The series of administrative adjudication cases, administrative litigation disputes, and patent invalidation cases involving the representation of the "Sofosbuvir" patent

代理“罗库溴铵”晶型专利无效案件的行政诉讼纠纷

The administrative litigation dispute over the invalidation of the crystalline form patent of "Rocuronium Bromide" by the agent

代理“吲哚布芬”晶型专利的系列无效案件纠纷

The series of invalidation disputes over the crystal form patent of "Indobufen" agents

代理“巴瑞替尼”晶型专利的行为保全复议案、专利无效案件及行政诉讼纠纷

The case of behavioral preservation reconsideration, patent invalidation, and administrative litigation disputes regarding the crystal form patent of "Baricitinib"

代理多家医药企业应对药品专利链接纠纷

Representing multiple pharmaceutical companies in drug patent linkage disputes.

长期为多家医药企业提供专利咨询服务，出具FTO分析报告及专利稳定性分析报告等

Long-term provision of patent consulting services for multiple pharmaceutical companies, including the preparation of FTO (Freedom-to-Operate) analysis reports and patent validity analysis reports.

Education